Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 6826175, 6 pages
http://dx.doi.org/10.1155/2016/6826175
Research Article

Effect of Alkaloids Isolated from Phyllodium pulchellum on Monoamine Levels and Monoamine Oxidase Activity in Rat Brain

1College of Pharmacy, Dalian Medical University, Dalian 116044, China
2Department of Neurosurgery, The Second Affiliated Hospital, Dalian Medical University, Dalian 116044, China
3Institute of Nationality Medicine in Guangxi, Nanning 530001, China

Received 30 September 2015; Revised 28 February 2016; Accepted 24 March 2016

Academic Editor: I-Min Liu

Copyright © 2016 Lu Cai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Wang, M. Zhong, B. Zhang et al., “Chemical constituents against hepatic fibrosis from Phyllodium pulchellum roots,” China Journal of Chinese Materia Medica, vol. 37, no. 2, pp. 424–427, 2014. View at Google Scholar
  2. J. Huang, M. Zhong, and S. Yu, “Effects of total alkaloids from Phyllodium pulchellum on proliferation of human hepatic stellate cells and collagen, cytokines related to hepatic fibrosis,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 19, no. 13, pp. 283–286, 2013. View at Google Scholar
  3. S. Ghosal, S. K. Banerjee, S. K. Bhattacharya, and A. K. Sanyal, “Chemical and pharmacological evaluation of Desmodium pulchellum,” Planta Medica, vol. 21, no. 4, pp. 398–409, 1972. View at Publisher · View at Google Scholar · View at Scopus
  4. C.-C. Shen, S.-T. Wang, S.-Y. Tsai, H.-C. Yang, B.-J. Shieh, and C.-C. Chen, “Cinnamylphenols from Phyllodium pulchellum,” Journal of Natural Products, vol. 68, no. 5, pp. 791–793, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Zong, M. Zhong, D.-M. Li et al., “Phenolic constituents from the roots of Phyllodium pulchellum,” Journal of Asian Natural Products Research, vol. 16, no. 7, pp. 741–746, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. E. L. Konrath, C. D. S. Passos, L. C. Klein-Júnior, and A. T. Henriques, “Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease,” Journal of Pharmacy and Pharmacology, vol. 65, no. 12, pp. 1701–1725, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. B. L. Roth, S. M. Hanizavareh, and A. E. Blum, “Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders,” Psychopharmacology, vol. 174, no. 1, pp. 17–24, 2004. View at Google Scholar · View at Scopus
  8. A.-M. Yu, “Indolealkylamines: biotransformations and potential drug-drug interactions,” AAPS Journal, vol. 10, no. 2, pp. 242–253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Miralles, S. Esteban, A. Sastre-Coll, D. Moranta, V. J. Asensio, and J. A. García-Sevilla, “High-affinity binding of β-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: Norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain,” European Journal of Pharmacology, vol. 518, no. 2-3, pp. 234–242, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Herraiz and C. Chaparro, “Human monoamine oxidase is inhibited by tobacco smoke: β-carboline alkaloids act as potent and reversible inhibitors,” Biochemical and Biophysical Research Communications, vol. 326, no. 2, pp. 378–386, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Baptista, A. Lacruz, X. Pàez, L. Hernàndez, and S. Beaulieu, “The antipsychotic drug sulpiride does not affect bodyweight in male rats. Is insulin resistance involved?” European Journal of Pharmacology, vol. 447, no. 1, pp. 91–98, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. M. M. Verheij and A. R. Cools, “Twenty years of dopamine research: individual differences in the response of accumbal dopamine to environmental and pharmacological challenges,” European Journal of Pharmacology, vol. 585, no. 2-3, pp. 228–244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Bjorvatn, J. Grønli, F. Hamre et al., “Effects of sleep deprivation on extracellular serotonin in hippocampus and frontal cortex of the rat,” Neuroscience, vol. 113, no. 2, pp. 323–330, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Hou, F. Jia, Y. Liu, and L. Li, “CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder,” Brain Research, vol. 1095, no. 1, pp. 154–158, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. C. W. Abell and S.-W. Kwan, “Molecular characterization of monoamine oxidases A and B,” Progress in Nucleic Acid Research and Molecular Biology, vol. 65, pp. 129–132, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. M. B. H. Youdim and Y. S. Bakhle, “Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness,” British Journal of Pharmacology, vol. 147, supplement1, pp. S287–S296, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Loomis and A. Hayes, Loomis's Essentials of Toxicology, Academic Press, San Diego, Calif, USA, 4th edition, 1996.
  18. F. Babin and T. Huynh-Dinh, “Chemical and enzymatic oxidative coupling of 5-hydroxy-N,N-dimethyltryptamine with amines,” Journal of Medicinal Chemistry, vol. 30, no. 7, pp. 1239–1241, 1987. View at Publisher · View at Google Scholar · View at Scopus
  19. F. M. Farias, C. S. Passos, M. D. Arbo et al., “Strictosidinic acid, isolated from Psychotria myriantha Mull. Arg. (Rubiaceae), decreases serotonin levels in rat hippocampus,” Fitoterapia, vol. 83, no. 6, pp. 1138–1143, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. B. R. Sitaram, L. Lockett, R. Talomsin, G. L. Blackman, and W. R. McLeod, “In vivo metabolism of 5-methoxy-N, N-dimethyltryptamine and N, N-dimethyltryptamine in the rat,” Biochemical Pharmacology, vol. 36, no. 9, pp. 1509–1512, 1987. View at Publisher · View at Google Scholar
  21. B. R. Sitaram and W. R. McLeod, “Observations on the metabolism of the psychotomimetic indolealkylamines: implications for future clinical studies,” Biological Psychiatry, vol. 28, no. 10, pp. 841–848, 1990. View at Publisher · View at Google Scholar · View at Scopus
  22. H.-W. Shen, X.-L. Jiang, J. C. Winter, and A.-M. Yu, “Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions,” Current Drug Metabolism, vol. 11, no. 8, pp. 659–666, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Yamada and H. Yasuhara, “Clinical pharmacology of MAO inhibitors: safety and future,” NeuroToxicology, vol. 25, no. 1-2, pp. 215–221, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Farzin and N. Mansouri, “Antidepressant-like effect of harmane and other β-carbolines in the mouse forced swim test,” European Neuropsychopharmacology, vol. 16, no. 5, pp. 324–328, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Litchfield Jr. and F. Wilcoxon, “A simplified method of evaluating dose-effect experiments,” Journal of Pharmacology and Experimental Therapeutics, vol. 96, no. 2, pp. 99–113, 1949. View at Google Scholar
  26. J. El Hilaly, Z. H. Israili, and B. Lyoussi, “Acute and chronic toxicological studies of Ajuga iva in experimental animals,” Journal of Ethnopharmacology, vol. 91, no. 1, pp. 43–50, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. J. L. P. Muñoz, R. M. Ceinos, J. L. Soengas, and J. M. Míguez, “A simple and sensitive method for determination of melatonin in plasma, bile and intestinal tissues by high performance liquid chromatography with fluorescence detection,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 877, no. 22, pp. 2173–2177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent.,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  29. D. van Diermen, A. Marston, J. Bravo, M. Reist, P.-A. Carrupt, and K. Hostettmann, “Monoamine oxidase inhibition by Rhodiola rosea L. roots,” Journal of Ethnopharmacology, vol. 122, no. 2, pp. 397–401, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. C. dos Santos Passos, T. C. Soldi, R. Torres Abib et al., “Monoamine oxidase inhibition by monoterpene indole alkaloids and fractions obtained from Psychotria suterella and Psychotria laciniata,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 28, no. 3, pp. 611–618, 2013. View at Publisher · View at Google Scholar · View at Scopus